SCHEMBL6170256

SCHEMBL6170256

CC1(Cc2ccnc(-c3ccccc3Cl)c2)NC(=O)N(c2ccc(S(=O)(=O)C(F)(F)F)cc2)C1=O

nearest known ligand 0.42

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 3/20 0.42
ITGAL P20701 1/20 0.39
AR P10275 3/20 0.36
AVPR2 P30518 1/20 0.36
AVPR1A P37288 1/20 0.36
KCNQ2 O43526 1/20 0.35
PTGS2 P35354 2/20 0.33
PTGS1 P23219 1/20 0.33
MAPT P10636 2/20 0.32
THRB P10828 1/20 0.32
KMT2A Q03164 1/20 0.32
TP53 P04637 1/20 0.32
MDM2 Q00987 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.31
RXFP1 Q9HBX9 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6174369 0.88 IGF1R (0.45) IGF1RITGALARKCNQ2PTGS2
SCHEMBL6173800 0.86 ITGAL (0.42) IGF1RITGALARPTGS2MAPT
SCHEMBL6177662 0.86 IGF1R (0.40) IGF1RITGALARPTGS2PTGS1
SCHEMBL6174653 0.85 ITGAL (0.39) IGF1RITGALARAVPR2AVPR1A
SCHEMBL6175072 0.85 IGF1R (0.48) IGF1RITGAL
SCHEMBL6177747 0.83 IGF1R (0.40) IGF1RITGALARPTGS2KMT2A
SCHEMBL6173575 0.82 IGF1R (0.44) IGF1RITGALARKMT2ATP53
SCHEMBL6174030 0.82 IGF1R (0.39) IGF1RITGALTP53SMN1; SMN2
SCHEMBL2942872 0.81 IGF1R (0.61) IGF1R
SCHEMBL6173222 0.81 MAPT (0.41) IGF1RITGALARPTGS2PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed